J&J to end global sales of talc-based baby powder

Aug 11 (Reuters) – Johnson & Johnson ( JNJ.N ) will stop selling talc-based baby powder globally in 2023, the drugmaker said on Thursday, more than two years after it ended US sales of a product that drew thousands of consumer safety lawsuits. “As part of a worldwide portfolio assessment, we have made the commercial … Read more

Moderna maintains vaccine sales view as demand from low-income nations eases

Syringes with needles are seen in front of a displayed Moderna logo in this illustration taken November 27, 2021. REUTERS/Dado Ruvic/Illustration/File Photo Register now for FREE unlimited access to Reuters.com Register Aug 3 (Reuters) – Moderna Inc (MRNA.O) on Wednesday retained its full-year sales outlook for COVID-19 shot at $21 billion due to decreasing orders … Read more

CVS Health lifts forecast as insurance business, COVID tests boost Q2 profit

CVS Health logo is seen displayed in this illustration taken, May 3, 2022. REUTERS/Dado Ruvic/Illustration Register now for FREE unlimited access to Reuters.com Register Aug 3 (Reuters) – CVS Health Corp (CVS.N) on Wednesday raised its annual profit forecast after strength in its insurance business and sales of COVID-19 over-the-counter test kits helped boost quarterly … Read more

Regeneron quarterly profit slumps as COVID antibody sales dry up

The Regeneron Pharmaceuticals company logo is seen on a building at the company’s Westchester campus in Tarrytown, New York, US September 17, 2020. Picture taken September 17, 2020. REUTERS/Brendan McDermid/File Photo Register now for FREE unlimited access to Reuters.com Register Aug 3 (Reuters) – Regeneron Pharmaceuticals (REGN.O) reported a 72.5% fall in quarterly profit on … Read more

Merck quarterly profit tops Wall Street view on strong Keytruda sales

Signage is seen at the Merck & Co. headquarters in Kenilworth, New Jersey, US, November 13, 2021. REUTERS/Andrew Kelly/File Photo Register now for FREE unlimited access to Reuters.com Register July 28 (Reuters) – Merck & Co (MRK.N) on Thursday reported higher-than-expected second-quarter earnings and revenue on strong sales of its blockbuster cancer drug Keytruda. The … Read more

Sanofi lifts profit outlook as Dupixent sales surge over 43%

Sanofi logo at the company’s headquarters during the annual results news conference in Paris, France, February 4, 2022. REUTERS/Benoit Tessier/ Register now for FREE unlimited access to Reuters.com Register July 28 (Reuters) – French healthcare group Sanofi (SASY.PA) lifted its full-year earnings outlook on continued strong sales growth for its bestselling drug Dupixent. In a … Read more